Nifty Pharma

The Nifty Pharma Index tracks 20 companies from India's pharmaceutical sector using a free-float market capitalisation methodology. The index provides a benchmark for tracking the performance of NIFTY pharma companies list.

The Nifty Pharma index value is calculated using the free-float market capitalisation of its constituents. Under this method, only shares readily available for public trading are considered when determining a company's weight in the index. 

The basic index calculation can be represented as: 

Index Value = Current Free-Float Market Capitalisation ÷ Base Market Capitalisation × Base Index Value 

The market value changes as the prices of the constituent companies change. Corporate actions, changes in free-float shares and periodic rebalancing are also considered under the index methodology. 

The index is reviewed twice a year. Changes arising from the review are implemented according to the prescribed index rules and schedule.

Companies need to satisfy specific conditions before they can form part of the index. The main criteria include: 

1. The company should be listed on the National Stock Exchange. 

2. It should form part of the eligible Nifty 500 universe. 

3. The company should belong to the pharmaceutical sector. 

4. The stock should have sufficient trading history. 

5. It should meet the required liquidity conditions. 

6. The company should satisfy the prescribed free-float market capitalisation requirements. 

7. Eligible securities should meet the relevant listing requirements. 

8. The stock should comply with the applicable index methodology. 

9. The constituent should qualify based on the selection and ranking process. 

These conditions help maintain the sector focus of the index.

The index uses free-float market capitalisation to determine the weight of each constituent. This means companies with a larger eligible market value have a greater influence on index movements. 

If a constituent has an approximate 24% weight at a particular rebalancing and its share price rises sharply while other constituents remain unchanged, the index can receive a relatively larger upward impact from that stock. A similar movement in a smaller constituent generally has a smaller effect on the index. 

This does not mean that the index always moves in line with one stock. Changes across all constituents; their respective weights and market movements determine the overall index value.

The Nifty Pharma index can provide several features for investors who want to study India's pharmaceutical sector: 

• Sector Diversification: It includes multiple pharmaceutical companies instead of focusing on one stock. 
• Exposure to the Pharma Sector: The index provides a benchmark for companies operating in the pharmaceutical industry. 
• Export Exposure: Several Indian pharmaceutical companies have international operations, giving the sector exposure to overseas markets. 
• ETF Availability: Investors can access products designed to track Nifty Pharma, subject to the product's structure and terms. 
• Periodic Rebalancing: The index is reviewed periodically according to its methodology. 
• Demat Access: Investors can access eligible listed stocks and exchange-traded products through the required market accounts. 

An index does not remove market risk, and each investment product linked to the index has its own costs and structure.

The Nifty Pharma Index was launched by NSE to represent India's pharmaceutical sector. 

The index is governed through NSE Indices' methodology and follows defined rules for constituent selection, weighting and rebalancing. Its purpose is to provide a sector-focused benchmark for the performance of eligible pharmaceutical companies.

The Nifty Pharma Index itself cannot be purchased directly because it is a market index rather than a security. Investors seeking exposure to the sector can consider products that track a pharma index or invest in individual constituent stocks. 

Investors may consider pharma-focused ETFs or index funds that track pharmaceutical-sector indices, subject to availability. Another route is a pharma-focused index mutual fund, where available. 

Before selecting a product, investors can review its investment objective, tracking method, expense ratio, liquidity, applicable charges and associated risks.

Nifty Pharma and Nifty 50 serve different purposes. Nifty Pharma focuses on pharmaceutical companies, while Nifty 50 represents 50 large companies across several sectors.

The pharmaceutical sector can show different performance patterns from the broader market because its companies face sector-specific factors.

Investors can follow these basic steps: 

Step 1: Open a Demat and trading account with a registered intermediary. 

Step 2: Search for the required Nifty Pharma stock or eligible pharma ETF. 

Step 3: Review the company's financial information, valuation, product details and relevant risks. 

Step 4: Place an order after considering the applicable charges and investment requirements. 

Investors can also explore eligible pharma-focused mutual funds instead of selecting individual stocks.

Nifty Pharma stocks are the companies that form part of the Nifty Pharma Index. Some of the leading constituents include Sun Pharmaceutical Industries, Dr. Reddy's Laboratories, Cipla, Divi's Laboratories and Lupin. Their approximate weights can change following market movements and index rebalancing.

The index itself cannot be traded like an individual share. Investors can access its constituent stocks individually, invest through an eligible pharma ETF such as PHARMABEES, or consider suitable pharma-focused index mutual funds. 

The index itself cannot be bought or sold. Individual constituent stocks can be traded according to applicable exchange rules. Eligible ETFs can also be traded on exchange trading days, subject to their market liquidity and applicable conditions.

Nifty Pharma provides focused sector exposure, but regulatory, currency, concentration and market risks remain relevant when assessing any investment linked to the index. 

Nifty Pharma represents 20 pharmaceutical companies, while Nifty 50 tracks 50 companies across different sectors. Nifty Pharma therefore provides sector-focused exposure, whereas Nifty 50 provides broader market exposure. 

Investors can look for eligible pharma-focused ETFs or index mutual funds that track a relevant pharmaceutical index. Before investing, review the fund's objective, tracking approach, expenses, liquidity, risk factors and applicable terms.